IMMX (STOCKS)
Immix Biopharma, Inc. Common Stock
$7.460000
+0.620000 (+9.06%)
Prev close: $6.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ilya Rachman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $393.72M
- Employees
- 21
- P/E (TTM)
- -9.45
- P/B (TTM)
- 27.34
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $524.67K |
| Operating Expenses | $24.05M |
| Research and Development | $11.91M |
| Other Operating Expenses | $12.14M |
| Operating Income/Loss | -$24.05M |
| Income/Loss From Continuing Operations After Tax | -$23.56M |
| Income/Loss From Continuing Operations Before Tax | -$23.53M |
| Income Tax Expense/Benefit | $37.24K |
| Net Income/Loss | -$23.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$23.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.77 |
| Diluted Earnings Per Share | -$0.77 |
| Basic Average Shares | 30,972,258 |
| Diluted Average Shares | 30,972,258 |
| Assets | $20.08M |
| Current Assets | $16.58M |
| Noncurrent Assets | $3.50M |
| Fixed Assets | $2.36M |
| Other Non-current Assets | $1.14M |
| Liabilities | $11.82M |
| Current Liabilities | $10.85M |
| Accounts Payable | $7.05M |
| Wages | $438.24K |
| Other Current Liabilities | $3.36M |
| Noncurrent Liabilities | $965.05K |
| Equity | $8.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.26M |
| Liabilities And Equity | $20.08M |
| Net Cash Flow From Operating Activities | -$14.38M |
| Net Cash Flow From Operating Activities, Continuing | -$14.38M |
| Net Cash Flow From Investing Activities | -$1.07M |
| Net Cash Flow From Investing Activities, Continuing | -$1.07M |
| Net Cash Flow From Financing Activities | $11.72M |
| Net Cash Flow From Financing Activities, Continuing | $11.72M |
| Exchange Gains/Losses | -$9.54K |
| Net Cash Flow | -$3.74M |
| Net Cash Flow, Continuing | -$3.73M |
| Comprehensive Income/Loss | -$23.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$23.76M |
| Other Comprehensive Income/Loss | -$195.68K |
| Other Comprehensive Income/Loss Attributable To Parent | -$129.59K |